Immunization with TG4010 appears biologically active in prostate cancer. Comment

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)56
Number of pages1
JournalOncology Report
Issue numberFALL
StatePublished - Sep 2005

Cite this